India has moved one step ahead in mosquito control by means of developing the Renofluthrin molecule thus placing India at the front of the world in fighting diseases which are carried by mosquitoes.
In a substantial change, the Union Health Ministry has unveiled comprehensive changes to rates for nearly 2,000 medical procedures under the Central Government Health Scheme (CGHS), the first major revision in rates since 2014...
Parexel has entered into a partnership deal with Weave Bio to simplify regulatory filing procedures and shorten the time to market of new treatments.
Apollo Hospitals, a major healthcare provider ranked among the top in Asia and known for its dependability, has signed a strategic partnership agreement with the Ministry of Interior, Republic of Iraq
.jpeg){kind=spacer}
JP Nadda, Union Minister for Health & Family Welfare and Chemicals & Fertilizers, had a one-on-one discussion with H.E. Dmitry Nikolaevich Patrushev, Deputy Prime Minister of the Russian Federation, at Nirman Bhavan, New Delhi.
Moderna has conveyed that the primary immunogenicity data for the 2025-2026 formula of mNEXSPIKE, the mRNA COVID-19 vaccine of their choice to the LP.8.1 variant of SARS-CoV-2, is in the positive range.
The revolutionary change that could dramatically impact the prevention of HIV may well hinge on how fast Indian regulators accept the proposal. Gilead Sciences, a US-based company, gave no-royalty licenses to four Indian firms
AbbVie announced that it has officially submitted a NDA to the USFDA for tavapadon, a next generation selective dopamine D1/D5 receptor partial agonist created to be taken once daily for oral administration for the treatment of Parkinson's...
Pfizer Inc. is poised to highlight key advances from its oncology portfolio at the European Society for Medical Oncology (ESMO) Congress 2025, which runs from October 17 to 21 in Berlin. With over 45 abstracts, including 11 oral and mini oral...
Illumina Inc. has announced global partnerships with top pharmaceutical companies for companion diagnostics (CDx) on Illumina’s TruSight Oncology (TSO) Comprehensive genomic profiling test. The collaboration focuses on KRAS alterations...
, CDSCO.jpg)